☰

Mincheol Park - Publications

Affiliations: 
2015-2020 Department of Pharmacology and Pharmaceutical Sciences University of Southern California, Los Angeles, CA, United States 
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tyrpak DR, Wang Y, Avila H, Guo H, Fu R, Truong AT, Park M, Okamoto CT, Hamm-Alvarez SF, MacKay JA. Caveolin elastin-like polypeptide fusions mediate temperature-dependent assembly of caveolar microdomains. Acs Biomaterials Science & Engineering. 6: 198-204. PMID 32542186 DOI: 10.1021/Acsbiomaterials.9B01331  0.469
2020 Vaikari VP, Park M, Keossayan L, MacKay JA, Alachkar H. Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia. Nanomedicine : Nanotechnology, Biology, and Medicine. 102236. PMID 32535112 DOI: 10.1016/J.Nano.2020.102236  0.552
2020 Park M, Vaikari VP, Lam AT, Zhang Y, MacKay JA, Alachkar H. Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32428520 DOI: 10.1016/J.Jconrel.2020.05.021  0.63
2020 Park M, Vaikari V, Dhandhukia J, Alachkar H, MacKay JA. A Human Granulocyte-Macrophage Colony-Stimulating Factor Fused to Elastin-like Polypeptides Assembles Biologically-Active Nanoparticles. Bioconjugate Chemistry. PMID 32319752 DOI: 10.1021/Acs.Bioconjchem.0C00204  0.651
2020 Vaikari VP, Park M, Mackay JA, Alachkar H. Abstract 537: Preclinical development and activity of Anti-FLT3 nanoworms in acute myeloid leukemia Cancer Research. 80: 537-537. DOI: 10.1158/1538-7445.Am2020-537  0.568
2018 Tiemann K, Garri C, Lee SB, Malihi PD, Park M, Alvarez RM, Yap LP, Mallick P, Katz JE, Gross ME, Kani K. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. Oncogene. PMID 30575818 DOI: 10.1038/S41388-018-0638-9  0.335
2018 Li Z, Tyrpak DR, Park M, Okamoto CT, MacKay JA. A new temperature-dependent strategy to modulate the epidermal growth factor receptor. Biomaterials. 183: 319-330. PMID 30196151 DOI: 10.1016/J.Biomaterials.2018.07.063  0.685
Show low-probability matches.